Prosight Management LP Acquires 235,060 Shares of OrthoPediatrics Corp. $KIDS

Prosight Management LP raised its holdings in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 319.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 308,707 shares of the company’s stock after buying an additional 235,060 shares during the period. OrthoPediatrics comprises approximately 1.3% of Prosight Management LP’s portfolio, making the stock its 26th largest position. Prosight Management LP owned about 1.23% of OrthoPediatrics worth $5,720,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of KIDS. Millennium Management LLC grew its position in shares of OrthoPediatrics by 55.3% in the 1st quarter. Millennium Management LLC now owns 656,578 shares of the company’s stock worth $16,172,000 after buying an additional 233,873 shares during the last quarter. Goldman Sachs Group Inc. lifted its stake in OrthoPediatrics by 112.3% in the first quarter. Goldman Sachs Group Inc. now owns 200,439 shares of the company’s stock worth $4,937,000 after acquiring an additional 106,041 shares during the period. Marshall Wace LLP boosted its holdings in OrthoPediatrics by 17.8% in the second quarter. Marshall Wace LLP now owns 419,129 shares of the company’s stock valued at $9,003,000 after acquiring an additional 63,345 shares in the last quarter. UBS Group AG increased its position in OrthoPediatrics by 64.8% during the 3rd quarter. UBS Group AG now owns 57,694 shares of the company’s stock valued at $1,069,000 after purchasing an additional 22,677 shares during the period. Finally, Grandeur Peak Global Advisors LLC purchased a new position in OrthoPediatrics during the 2nd quarter valued at $452,000. 69.05% of the stock is owned by hedge funds and other institutional investors.

OrthoPediatrics Price Performance

KIDS opened at $17.31 on Friday. The company has a current ratio of 5.55, a quick ratio of 2.65 and a debt-to-equity ratio of 0.28. The company has a market cap of $437.60 million, a price-to-earnings ratio of -10.24 and a beta of 1.07. The stock has a fifty day simple moving average of $17.76 and a two-hundred day simple moving average of $18.05. OrthoPediatrics Corp. has a 12-month low of $15.28 and a 12-month high of $26.40.

OrthoPediatrics (NASDAQ:KIDS) last announced its earnings results on Thursday, February 26th. The company reported ($0.26) EPS for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.11. The firm had revenue of $61.61 million for the quarter, compared to analysts’ expectations of $61.27 million. OrthoPediatrics had a negative net margin of 16.77% and a negative return on equity of 6.70%. Research analysts predict that OrthoPediatrics Corp. will post -0.93 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have recently commented on KIDS. Wall Street Zen raised shares of OrthoPediatrics from a “sell” rating to a “hold” rating in a research report on Saturday, March 7th. BTIG Research boosted their price target on shares of OrthoPediatrics from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Friday, February 27th. Canaccord Genuity Group started coverage on shares of OrthoPediatrics in a research note on Wednesday, December 10th. They issued a “buy” rating and a $24.00 price target for the company. Weiss Ratings restated a “sell (e+)” rating on shares of OrthoPediatrics in a report on Thursday, January 22nd. Finally, Truist Financial raised their price objective on shares of OrthoPediatrics from $19.00 to $20.00 and gave the stock a “hold” rating in a report on Monday, March 2nd. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $24.67.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.